this post was submitted on 21 Oct 2023
2141 points (97.5% liked)

Technology

69041 readers
4383 users here now

This is a most excellent place for technology news and articles.

Our Rules

  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots

founded 2 years ago
MODERATORS
L3s@lemmy.world
enu@lemmy.world
technopagan@lemmy.world
L4s@lemmy.world
L3s@hackingne.ws
L4s@hackingne.ws
2141
Pfizer says it will price Covid treatment Paxlovid at nearly $1,400 for a five-day course, which researchers estimate only costs Pfizer $13 to produce. That's a 10,000%+ markup. Shameful. (mastodon.world)
submitted 2 years ago by i_have_no_enemies@lemmy.world to c/technology@lemmy.world
294 comments fedilink hide all child comments
you are viewing a single comment's thread
view the rest of the comments
[–] be_excellent_to_each_other@kbin.social -2 points 2 years ago (1 children)

From the passage I already quoted:

In reality, public sources — especially the NIH — fund the basic research that makes scientific breakthroughs. Then small, boutique biotech and pharmaceutical firms take that publicly generated knowledge and do the final stages of research, like running clinical trials, that get the drugs to market.

[–] Quereller@lemmy.one 4 points 2 years ago* (last edited 2 years ago) (1 children)

That is not true. Small biotech usually cannot effort late stage development. They either just get buyed by big pharma. Or they licence the lead compound to big pharma and get royalties. Very few exemptions to this.

Edit: the link you provide cites this FT article as a source for this claim. However the article is about M&A and supports my point.

[–] be_excellent_to_each_other@kbin.social 0 points 2 years ago (1 children)

I'll assume you know more about this than I do despite the lack of any citation.

I refuse to believe there's an ethically acceptable business justification for this ridiculous markup.

The entire healthcare industry in the US is built on a foundation of corporate greed. This is just one obvious example.

[–] Quereller@lemmy.one 1 points 2 years ago

At least they loose exclusivity after 15 -20 years and generics are usually much cheaper.